• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Retraction notice to "A feasibility study of the combination of intranasal insulin with dulaglutide for cognition in older adults with metabolic syndrome at high dementia risk- Study rationale and design" [Mech. Ageing Dev. 213 (2023) 111825].

作者信息

Davidy Tal, Yore Iscka, Cukierman-Yaffe Tali, Ravona-Springer Ramit, Livny Abigail, Lesman-Segev Orit H, Azuri Yossi, Carmichael Owen, Kapogiannis Dimitrios, Zetterberg Henrik, Lin HungMo, Sano Mary, Beeri Michal Schnaider

机构信息

The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel; Department of Neurology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel.

The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel.

出版信息

Mech Ageing Dev. 2024 Jun;219:111937. doi: 10.1016/j.mad.2024.111937. Epub 2024 May 3.

DOI:10.1016/j.mad.2024.111937
PMID:38702256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12124240/
Abstract
摘要

相似文献

1
Retraction notice to "A feasibility study of the combination of intranasal insulin with dulaglutide for cognition in older adults with metabolic syndrome at high dementia risk- Study rationale and design" [Mech. Ageing Dev. 213 (2023) 111825].撤回通知：“鼻内胰岛素与度拉糖肽联合应用于高痴呆风险的代谢综合征老年人认知功能的可行性研究——研究原理与设计”[《衰老与发育机制》213卷（2023年）111825页]
Mech Ageing Dev. 2024 Jun;219:111937. doi: 10.1016/j.mad.2024.111937. Epub 2024 May 3.
2
A feasibility study of the combination of intranasal insulin with dulaglutide for cognition in older adults with metabolic syndrome at high dementia risk - Study rationale and design.鼻内胰岛素与度拉糖肽联合应用对高痴呆风险的代谢综合征老年人认知功能影响的可行性研究——研究原理与设计
Mech Ageing Dev. 2023 Jul;213:111825. doi: 10.1016/j.mad.2023.111825. Epub 2023 May 26.
3
A feasibility study of the combination of intranasal insulin with oral semaglutide for cognition in older adults with metabolic syndrome at high dementia risk- Study rationale and design.鼻内胰岛素与口服司美格鲁肽联合应用于高痴呆风险的老年代谢综合征患者认知功能的可行性研究——研究原理与设计
Mech Ageing Dev. 2024 Apr;218:111898. doi: 10.1016/j.mad.2023.111898. Epub 2023 Dec 29.
4
Retraction notice to 'Drosophila Ten-a is a maternal pair-rule and patterning gene' [Mech. Dev. 124 (2007) 911-924].撤回通知：“果蝇Ten-a是一个母体成对规则和模式形成基因”[《机制与发育》124 (2007) 911 - 924]
Mech Dev. 2012 Mar-Jun;129(1-4):73. doi: 10.1016/j.mod.2011.12.001.
5
Memory advancement by intranasal insulin in type 2 diabetes (MemAID) randomized controlled clinical trial: Design, methods and rationale.经鼻内胰岛素改善 2 型糖尿病患者记忆的随机对照临床试验（MemAID）：设计、方法和原理。
Contemp Clin Trials. 2020 Feb;89:105934. doi: 10.1016/j.cct.2020.105934. Epub 2020 Jan 7.
6
Resveratrol and Dulaglutide ameliorate adiposity and liver dysfunction in rats with diet-induced metabolic syndrome: Role of SIRT-1 / adipokines / PPARγ and IGF-1.白藜芦醇和度拉糖肽改善饮食诱导代谢综合征大鼠的肥胖和肝功能障碍：SIRT-1/脂联素/PPARγ和 IGF-1 的作用。
Daru. 2023 Jun;31(1):13-27. doi: 10.1007/s40199-023-00458-y. Epub 2023 Mar 29.
7
Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial.经鼻给予胰岛素治疗轻度认知障碍和阿尔茨海默病痴呆的安全性、有效性和可行性：一项随机临床试验。
JAMA Neurol. 2020 Sep 1;77(9):1099-1109. doi: 10.1001/jamaneurol.2020.1840.
8
Sodium-Glucose Cotransporter-2 Inhibitors, Dulaglutide, and Risk for Dementia : A Population-Based Cohort Study.钠-葡萄糖共转运蛋白 2 抑制剂、度拉糖肽与痴呆风险：一项基于人群的队列研究。
Ann Intern Med. 2024 Oct;177(10):1319-1329. doi: 10.7326/M23-3220. Epub 2024 Aug 27.
9
Double-Blind Placebo-Controlled Pilot Investigation of the Safety of a Single Dose of Rapid-Acting Intranasal Insulin in Down Syndrome.一项关于单次快速作用鼻内胰岛素用于唐氏综合征安全性的双盲安慰剂对照初步研究。
Drugs R D. 2020 Mar;20(1):11-15. doi: 10.1007/s40268-020-00296-2.
10
Corrigendum to "Evaluation of senescent cells in intervertebral discs by lipofuscin staining" [Mech. Ageing Dev. 199 (2021) 1-9/111564].
Mech Ageing Dev. 2022 Jan;201:111603. doi: 10.1016/j.mad.2021.111603. Epub 2021 Nov 18.